Mental Health Clinician

Ketamine for the treatment of major depressive disorder and bipolar depression: A review of the literature

This literature review (2017) of randomised, placebo-controlled trials explores the effects of ketamine in treatment-resistant depression (TRD) and bipolar depression (BD). Ketamine reduced symptoms in both and is a promising compound for those who have found other treatments lacking.

Published

January 1, 2017

Journal

Mental Health Clinician

Authors

Grady, S. E., Marsh, T. A., Tenhouse, A., Klein, K.